M&A

News

Stada CEO confirms company may be for sale

Rumours that German pharma Stada may be up for sale have been all but confirmed by the company's chief executive, who told a news agency that "exploratory talks" are takin

News

Harmony buys cannabidiol firm Zynerba in $200m deal

Neuroscience specialist Harmony Biosciences has agreed to acquire Zynerba, adding its cannabidiol (CBD) gel product Zygel for Fragile X syndrome and other rare neuropsychi

News

Novo Nordisk buys Inversago for $1bn as Wegovy sales soar

Sales of its obesity therapies may be accelerating, but Novo Nordisk is showing no signs of pushing the brake pedal on investments in the category.

News

Regeneron dials up in gene therapy with Decibel deal

Regeneron has agreed a $109 million deal to acquire Decibel Therapeutics and its early-stage gene therapy for a form of congenital deafness, several years after forming a

News

eureKING buys SCTbio to extend biomanufacturing push

Special purpose acquisition company (SPAC) eureKING has agreed a deal to buy SCTbio as part of a plan to build a contract manufacturing company specialising in biologic th

News

PacBio builds in short-read sequencing with $110m Apton buy

Gene sequencing specialist PacBio has reached an agreement to buy Apton Biosystems, boosting its position in short-read sequencing technology that has traditionally been d

Stada CEO confirms company may be for sale

Harmony buys cannabidiol firm Zynerba in $200m deal

Novo Nordisk buys Inversago for $1bn as Wegovy sales soar

Regeneron dials up in gene therapy with Decibel deal

eureKING buys SCTbio to extend biomanufacturing push

PacBio builds in short-read sequencing with $110m Apton buy

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

M&A

Editor's Picks